356 related articles for article (PubMed ID: 21348558)
1. Comparison of healthcare utilization among patients treated with alcoholism medications.
Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
[TBL] [Abstract][Full Text] [Related]
2. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
Baser O; Chalk M; Rawson R; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
[TBL] [Abstract][Full Text] [Related]
3. Cost and utilization outcomes of opioid-dependence treatments.
Baser O; Chalk M; Fiellin DA; Gastfriend DR
Am J Manag Care; 2011 Jun; 17 Suppl 8():S235-48. PubMed ID: 21761950
[TBL] [Abstract][Full Text] [Related]
4. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
[TBL] [Abstract][Full Text] [Related]
5. Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization.
Bryson WC; McConnell J; Korthuis PT; McCarty D
Am J Manag Care; 2011 Jun; 17 Suppl 8(Suppl 8):S222-34. PubMed ID: 21761949
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.
Harris AH; Kivlahan DR; Bowe T; Humphreys KN
Psychiatr Serv; 2010 Apr; 61(4):392-8. PubMed ID: 20360279
[TBL] [Abstract][Full Text] [Related]
7. The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt JC
J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
[TBL] [Abstract][Full Text] [Related]
8. Extended-release naltrexone for alcohol and opioid dependence: a meta-analysis of healthcare utilization studies.
Hartung DM; McCarty D; Fu R; Wiest K; Chalk M; Gastfriend DR
J Subst Abuse Treat; 2014 Aug; 47(2):113-21. PubMed ID: 24854219
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
[TBL] [Abstract][Full Text] [Related]
10. Physicians' opinions about medications to treat alcoholism.
Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
[TBL] [Abstract][Full Text] [Related]
11. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
Petrov I; Krogh J; Nordentoft M
Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
[TBL] [Abstract][Full Text] [Related]
12. Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.
Zarkin GA; Bray JW; Aldridge A; Mitra D; Mills MJ; Couper DJ; Cisler RA;
Arch Gen Psychiatry; 2008 Oct; 65(10):1214-21. PubMed ID: 18838638
[TBL] [Abstract][Full Text] [Related]
13. New pharmacotherapies for alcohol dependence.
Graham R; Wodak AD; Whelan G
Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
[TBL] [Abstract][Full Text] [Related]
14. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
Buri C; Moggi F; Giovanoli A; Strik W
Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
[TBL] [Abstract][Full Text] [Related]
15. New pharmacotherapies for alcohol dependence: are they being used and what do they cost?
Doran CM; Fawcett JE; Shakeshaft AP; Shanahan MD; Mattick RP
Med J Aust; 2003 Aug; 179(4):218. PubMed ID: 12914502
[No Abstract] [Full Text] [Related]
16. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty.
Mark TL; Kassed CA; Vandivort-Warren R; Levit KR; Kranzler HR
Drug Alcohol Depend; 2009 Jan; 99(1-3):345-9. PubMed ID: 18819759
[TBL] [Abstract][Full Text] [Related]
17. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
18. Trends in the adoption of medications for alcohol dependence.
Ducharme LJ; Knudsen HK; Roman PM
J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S13-9. PubMed ID: 17114950
[TBL] [Abstract][Full Text] [Related]
19. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
